UnitedHealth (UNH) Reports Q4 Earnings: What Key Metrics Have to Say

Core Insights - UnitedHealth Group reported $100.81 billion in revenue for Q4 2024, a year-over-year increase of 6.8% [1] - The EPS for the same period was $6.81, compared to $6.16 a year ago, with a surprise of +1.49% against the consensus estimate of $6.71 [1] Revenue Performance - The reported revenue of $100.81 billion was below the Zacks Consensus Estimate of $102.25 billion, resulting in a surprise of -1.41% [1] - Investment and other income reached $1.55 billion, exceeding the estimate of $1.21 billion by 31.6% year-over-year [4] - Products revenue was $13.48 billion, surpassing the $13.04 billion estimate, reflecting a 19.1% increase year-over-year [4] - Services revenue was $9.30 billion, slightly below the estimate of $9.37 billion, with a year-over-year increase of 6.8% [4] - Premiums revenue was $76.48 billion, lower than the $78.16 billion estimate, showing a 4.5% year-over-year increase [4] - Optum Rx revenue was $35.77 billion, exceeding the estimate of $35.34 billion, with a year-over-year increase of 14.8% [4] - Optum Health revenue was $25.66 billion, below the estimate of $27.28 billion, reflecting a 4.6% year-over-year increase [4] - Total UnitedHealthcare revenue was $74.13 billion, lower than the $75.52 billion estimate, with a year-over-year increase of 4.7% [4] Customer Metrics - Total medical customers served by UnitedHealthcare reached 50.68 million, exceeding the average estimate of 50.36 million [4] - Total domestic commercial customers served was 29.73 million, in line with the average estimate of 29.7 million [4] - Risk-based commercial domestic customers were 8.85 million, slightly below the average estimate of 8.87 million [4] - Fee-based commercial domestic customers were 20.89 million, slightly above the average estimate of 20.83 million [4] Stock Performance - UnitedHealth shares returned +8.7% over the past month, outperforming the Zacks S&P 500 composite's -1.6% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]